Risk-based prediction for optimal timing of booster vaccination for COVID-19 to prevent severe disease
Hailey J. Park, Gregg S. Gonsalves, Sophia T. Tan, J. Daniel Kelly, George W. Rutherford, Robert M. Wachter, Robert Schechter, View ORCID ProfileA. David Paltiel, View ORCID ProfileNathan C. Lo
doi: https://doi.org/10.1101/2023.07.10.23292473
Hailey J. Park
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA
2Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, USA
Gregg S. Gonsalves
3Department of Epidemiology of Microbial Diseases and Public Health Modeling Unit, Yale School of Public Health, New Haven, CT, USA
Sophia T. Tan
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA
2Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, USA
J. Daniel Kelly
4Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA
5Institute for Global Health Sciences, University of California, San Francisco, San Francisco, CA, USA
6F.I. Proctor Foundation, University of California, San Francisco, San Francisco, CA, USA
George W. Rutherford
4Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, CA, USA
5Institute for Global Health Sciences, University of California, San Francisco, San Francisco, CA, USA
Robert M. Wachter
7Department of Medicine, University of California, San Francisco, San Francisco, CA, USA
Robert Schechter
8California Department of Public Health, Richmond, CA, USA
A. David Paltiel
9Department of Health Policy and Management and Public Health Modeling Unit, Yale School of Public Health, New Haven, CT, USA
Nathan C. Lo
1Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA
2Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, USA

Article usage
Posted July 12, 2023.
Risk-based prediction for optimal timing of booster vaccination for COVID-19 to prevent severe disease
Hailey J. Park, Gregg S. Gonsalves, Sophia T. Tan, J. Daniel Kelly, George W. Rutherford, Robert M. Wachter, Robert Schechter, A. David Paltiel, Nathan C. Lo
medRxiv 2023.07.10.23292473; doi: https://doi.org/10.1101/2023.07.10.23292473
Risk-based prediction for optimal timing of booster vaccination for COVID-19 to prevent severe disease
Hailey J. Park, Gregg S. Gonsalves, Sophia T. Tan, J. Daniel Kelly, George W. Rutherford, Robert M. Wachter, Robert Schechter, A. David Paltiel, Nathan C. Lo
medRxiv 2023.07.10.23292473; doi: https://doi.org/10.1101/2023.07.10.23292473
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)